Post-earnings recap
Reported
Wed, Aug 12, 2026
EPS actual
$1.64
EPS est.
$1.35
EPS surprise
+21.03%
1-day move
+18.69%
Marex Group Limited's strong earnings report indicates robust financial health and effective growth strategies. The stock's 18.69% increase reflects investor confidence following a record profit and significant year-on-year revenue growth. The company is well-positioned for continued success, especially with an expanding client base and organic profit growth.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.64 | N/A | +21.03% |
| Revenue | $696 million | N/A | N/A |
| Adjusted Profit Before Tax | $166 million | N/A | N/A |
| Return on Equity | 37.5% | N/A | N/A |
Management expressed confidence in the company's sustained growth, highlighting a significant increase in client revenue generation. They noted the effectiveness of their growth strategy, which is reflected in the strong financial results.
Marex achieved a record profit for the sixth consecutive quarter.
80% of year-on-year profit growth in Q2 was organic.
Marex Group plc (MRX) is a financial services company that specializes in investment banking and brokerage. With a market cap of $4 billion, it plays a significant role in the financial sector, providing services that facilitate trading and investment activities for various clients.
Last quarter
In Q1-2026, Marex reported an EPS of $1.48, exceeding estimates by 5.71%. However, the stock fell by 5.90% the following day, indicating market concerns despite the earnings beat.
EPS beat streak
8Q
EPS beat rate
100%
Avg EPS surprise
+12.17%
Avg 1-day reaction
+1.68%
Investors are keenly watching Marex's upcoming earnings report, especially given its strong history of beating EPS estimates. However, the recent stock price decline raises questions about market sentiment.
Bull case
If Marex continues its trend of beating EPS estimates, it could signal strong operational performance and boost investor confidence, potentially leading to a stock price increase.
Bear case
Conversely, if the company fails to meet expectations or provides weak guidance, it could exacerbate recent stock declines and raise concerns about its future growth.
The print will turn on these.
Q1
What will be the EPS for Q2-2026?
Given Marex's history of beating EPS estimates, the market will closely watch this figure to gauge the company's financial health.
Q2
How does Marex plan to address recent stock price declines?
Management's commentary on strategies to improve stock performance will be crucial for investor sentiment moving forward.
—
Est. EPS
$0.20
Est. Rev
$609M
Impl. Move
±12.7%
Why consensus could be wrong
The Street may underestimate Marex's ability to maintain its earnings momentum despite recent stock price declines. Investors could be overly cautious based on short-term price movements rather than the company's strong fundamentals.
Supporting evidence
Marex has consistently beaten EPS estimates, indicating strong operational performance.
The options market is pricing a modest move, suggesting limited expectations for volatility, which may not reflect the company's potential.
Historical patterns show that the stock has often reacted positively to earnings beats, despite initial declines.
Key risk
If Marex reports an EPS above $1.50, it could challenge the current cautious sentiment in the market.
Pre-commit to what would confirm each case.
The market is debating whether Marex can sustain its positive earnings trajectory amid recent stock price pressures.
Bull confirmed if
An EPS of $1.50 or higher would confirm the bull case and indicate strong operational performance.
Bear confirmed if
An EPS below $1.40 would confirm the bear case and raise concerns about the company's growth prospects.
What the market is pricing for the move.
Implied Move
±2.36%
Historical Avg
±5.4%
The options market is pricing in a relatively modest move of 2.36%, suggesting that traders expect limited volatility around the earnings announcement.
Options are pricing ±2.4% while MRX has averaged ±5.4% over the last 8 prints — setup is pricing cheap.
ATM IV
0.5%
30d HV
44.2%
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options pricing cheap in Financials
Fade rate: 12 of 25 (48%)
This setup has occurred 30 times across Financials in the last 2 years. 12 of 25 faded and 13 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 2.4%, with a raw directional average of -0.0% (roughly flat historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
81.75%
of float
Insider
6.80%
of float
Holders
315
institutions
Top Holders· as of Jun 2026
FMR, LLC
5,368,485 sh · $385.9M
0.00%
54.2%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Marex beats expectations, history suggests the stock could rise by around 1.27%, confirming strong operational performance.
In line / cautious
If results are in line with expectations, the stock may experience muted movement as investors await further guidance.
Miss
A miss could lead to a decline, with historical patterns indicating a potential drop in the range of 4.95%.
The lines on the call that would change the story.
Price (T.Rowe) Associates Inc
4,923,341 sh · $353.9M
0.00%
158.3%
Blackrock Inc.
4,594,149 sh · $330.2M
0.00%
4.7%
Capital International Investors
3,264,364 sh · $234.6M
0.00%
-6.4%
Alliancebernstein L.P.
2,600,436 sh · $186.9M
0.00%
50.3%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.